{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:01:48Z","timestamp":1793379708402,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u201cPioneer\u201d and \u201cLeading goose\u201d R&D Program of Zhejiang","award":["2024SSYS0032, 2022C03102"],"award-info":[{"award-number":["2024SSYS0032, 2022C03102"]}]},{"name":"Research Program of Westlake Laboratory of Life Sciences and Biomedicine","award":["202208012"],"award-info":[{"award-number":["202208012"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073529"],"award-info":[{"award-number":["82073529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073546"],"award-info":[{"award-number":["82073546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research and Development Program of Guangzhou, China","award":["202007040003"],"award-info":[{"award-number":["202007040003"]}]},{"name":"5010 Program for Clinical Researches of the Sun Yat-sen University","award":["2007032"],"award-info":[{"award-number":["2007032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-024-02409-6","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T13:02:38Z","timestamp":1725109358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Two-week continuous glucose monitoring-derived metrics and degree of hepatic steatosis: a cross-sectional study among Chinese middle-aged and elderly participants"],"prefix":"10.1186","volume":"23","author":[{"given":"Haili","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Sheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"issue":"3","key":"2409_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol. 2019;70(3):531\u201344.","journal-title":"J Hepatol"},{"issue":"12","key":"2409_CR2","doi-asserted-by":"publisher","DOI":"10.2196\/34809","volume":"8","author":"H Chen","year":"2022","unstructured":"Chen H, Zhan Y, Zhang J, et al. The global, regional, and national burden and trends of NAFLD in 204 countries and territories: an analysis from global burden of disease 2019. JMIR Public Health Surveill. 2022;8(12): e34809.","journal-title":"JMIR Public Health Surveill"},{"issue":"11","key":"2409_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","volume":"6","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Csermely A, Petracca G, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(11):903\u201313.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"2409_CR4","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3390\/nu15102323","volume":"15","author":"N Bhat","year":"2023","unstructured":"Bhat N, Mani A. Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease. Nutrients. 2023;15(10):2323.","journal-title":"Nutrients"},{"issue":"Suppl 1","key":"2409_CR5","first-page":"S111","volume":"47","author":"Glycemic Goals and Hypoglycemia","year":"2024","unstructured":"Glycemic Goals and Hypoglycemia. Standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S111\u201325.","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"2409_CR6","first-page":"S3","volume":"18","author":"D Rodbard","year":"2016","unstructured":"Rodbard D. Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther. 2016;18(Suppl 2):S3\u201313.","journal-title":"Diabetes Technol Ther"},{"issue":"Supplement_1","key":"2409_CR7","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.2337\/dc23-S007","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"ElSayed NA, Aleppo G, Bannuru RR, et al. Glycemic goals and hypoglycemia: standards of care in diabetes\u20142024. Diabetes Care. 2024;47(Supplement_1):S111\u201325.","journal-title":"Diabetes Care"},{"key":"2409_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.metabol.2017.11.017","volume":"84","author":"E Poggiogalle","year":"2018","unstructured":"Poggiogalle E, Jamshed H, Peterson CM. Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism. 2018;84:11\u201327.","journal-title":"Metabolism"},{"issue":"1","key":"2409_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","volume":"11","author":"T Battelino","year":"2023","unstructured":"Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11(1):42\u201357.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2409_CR10","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20230108","author":"C Ling","year":"2023","unstructured":"Ling C, Zhong H, Zeng F, et al. Cohort Profile: Guangzhou Nutrition and Health Study (GNHS): A Population-Based Multi-Omics Study. J Epidemiol. 2023. https:\/\/doi.org\/10.2188\/jea.JE20230108.","journal-title":"J Epidemiol"},{"issue":"5","key":"2409_CR11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cmet.2023.04.002","volume":"35","author":"A Keshet","year":"2023","unstructured":"Keshet A, Shilo S, Godneva A, et al. CGMap: characterizing continuous glucose monitor data in thousands of non-diabetic individuals. Cell Metab. 2023;35(5):758\u201369.","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"2409_CR12","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1089\/dia.2008.0132","volume":"11","author":"D Rodbard","year":"2009","unstructured":"Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11(Suppl 1):S55\u201367.","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"2409_CR13","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2337\/dc18-1581","volume":"41","author":"RM Bergenstal","year":"2018","unstructured":"Bergenstal RM, Beck RW, Close KL, et al. Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41(11):2275\u201380.","journal-title":"Diabetes Care"},{"issue":"6","key":"2409_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.amjms.2018.09.010","volume":"356","author":"GE Umpierrez","year":"2018","unstructured":"Umpierrez GE, Kovatchev BP. Glycemic variability: how to measure and its clinical implication for type 2 diabetes. Am J Med Sci. 2018;356(6):518\u201327.","journal-title":"Am J Med Sci"},{"issue":"9","key":"2409_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2337\/diab.19.9.644","volume":"19","author":"GD Molnar","year":"1970","unstructured":"Service F J, Molnar GD, Rosevear JW, et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19(9):644\u201355.","journal-title":"Diabetes"},{"issue":"1","key":"2409_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/cmb.2022.0100","volume":"30","author":"J Shao","year":"2023","unstructured":"Shao J, Liu Z, Li S, et al. Continuous Glucose Monitoring Time Series Data Analysis: A Time Series Analysis Package for Continuous Glucose Monitoring Data. J Comput Biol. 2023;30(1):112\u20136.","journal-title":"J Comput Biol"},{"issue":"8","key":"2409_CR17","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"3","key":"2409_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/ije\/dyaa004","volume":"49","author":"LAC Millard","year":"2020","unstructured":"Millard LAC, Patel N, Tilling K, et al. GLU: a software package for analysing continuously measured glucose levels in epidemiology. Int J Epidemiol. 2020;49(3):744\u201357.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"2409_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.29639","volume":"67","author":"C Caussy","year":"2018","unstructured":"Caussy C, Alquiraish MH, Nguyen P, et al. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology (Baltimore, MD). 2018;67(4):1348\u201359.","journal-title":"Hepatology (Baltimore, MD)"},{"key":"2409_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13098-019-0440-z","volume":"11","author":"J Ye","year":"2019","unstructured":"Ye J, Hu X, Wu T, et al. Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study. Diabetol Metab Syndr. 2019;11:45.","journal-title":"Diabetol Metab Syndr"},{"key":"2409_CR21","first-page":"3149","volume":"30","author":"G Ke","year":"2017","unstructured":"Ke G, Qi M, Finley T, et al. LightGBM: a highly efficient gradient boosting decision tree. NIPS. 2017;30:3149\u201357.","journal-title":"NIPS"},{"key":"2409_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2023.107605","volume":"174","author":"X Fu","year":"2023","unstructured":"Fu X, Mao X, Wu H, et al. Development and validation of LightGBM algorithm for optimizing of Helicobacter pylori antibody during the minimum living guarantee crowd based gastric cancer screening program in Taizhou, China. Prev Med. 2023;174: 107605.","journal-title":"Prev Med"},{"key":"2409_CR23","unstructured":"Lundberg SM, Lee S. A unified approach to interpreting model predictions. NIPS, 2017:4768\u20134777."},{"issue":"6","key":"2409_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology (Baltimore, MD). 2006;43(6):1317\u201325.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"1","key":"2409_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12944-020-01326-3","volume":"19","author":"Y Zou","year":"2020","unstructured":"Zou Y, Yu M, Sheng G. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study. Lipids Health Dis. 2020;19(1):145.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2409_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12876-022-02615-0","volume":"22","author":"J Deng","year":"2022","unstructured":"Deng J, Han Z, Tang H, et al. Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals. BMC Gastroenterol. 2022;22(1):521.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"2409_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ctg.0000000000000042","volume":"10","author":"C Hsu","year":"2019","unstructured":"Hsu C, Wu F, Lin K, et al. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup. Clin Transl Gastroenterol. 2019;10(5):1\u20138.","journal-title":"Clin Transl Gastroenterol"},{"key":"2409_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108922","volume":"177","author":"S Hong","year":"2021","unstructured":"Hong S, Lee JS, Kim JA, et al. Glycemic variability and the risk of nonalcoholic fatty liver disease: a nationwide population-based cohort study. Diabetes Res Clin Pract. 2021;177: 108922.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"2409_CR29","doi-asserted-by":"publisher","first-page":"e2301","DOI":"10.1210\/clinem\/dgac122","volume":"107","author":"H Zhou","year":"2022","unstructured":"Zhou H, Zeng X, Xue Y, et al. Visit-to-visit fasting glucose variability in young adulthood and nonalcoholic fatty liver disease in middle age. J Clin Endocrinol Metab. 2022;107(6):e2301\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2409_CR30","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.dsx.2021.03.004","volume":"15","author":"R Ravi","year":"2021","unstructured":"Ravi R, Balasubramaniam V, Kuppusamy G, et al. Current concepts and clinical importance of glycemic variability. Diabetes Metab Syndr. 2021;15(2):627\u201336.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"2409_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-020-01085-6","volume":"19","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Sun B, Huang S, et al. Glycemic variability: adverse clinical outcomes and how to improve it? Cardiovasc Diabetol. 2020;19(1):102.","journal-title":"Cardiovasc Diabetol"},{"key":"2409_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fendo.2017.00236","volume":"8","author":"R Noordam","year":"2017","unstructured":"Noordam R, Vermond D, Drenth H, et al. High liver enzyme concentrations are associated with higher glycemia, but not with glycemic variability, in individuals without diabetes mellitus. Front Endocrinol. 2017;8:236.","journal-title":"Front Endocrinol"},{"issue":"2","key":"2409_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/dia.2010.0101","volume":"13","author":"H Bian","year":"2011","unstructured":"Bian H, Yan H, Zeng M, et al. Increased liver fat content and unfavorable glucose profiles in subjects without diabetes. Diabetes Technol Ther. 2011;13(2):149\u201355.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2409_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000441842","volume":"85","author":"R Schiaffini","year":"2016","unstructured":"Schiaffini R, Liccardo D, Alisi A, et al. Early glucose derangement detected by continuous glucose monitoring and progression of liver fibrosis in nonalcoholic fatty liver disease: an independent predictive factor? Horm Res Paediatr. 2016;85(1):29\u201334.","journal-title":"Horm Res Paediatr"},{"key":"2409_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241250355","author":"AM Bowler","year":"2024","unstructured":"Bowler AM, Burke LM, Coffey VG, et al. Day-to-day glycemic variability using continuous glucose monitors in endurance athletes. J Diabetes Sci Technol. 2024. https:\/\/doi.org\/10.1177\/19322968241250355.","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"2409_CR36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.clnu.2024.02.014","volume":"43","author":"A Hjort","year":"2024","unstructured":"Hjort A, Iggman D, Rosqvist F. Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: a systematic review and meta-analysis. Clin Nutr (Edinburgh, Scotland). 2024;43(4):915\u201325.","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"24","key":"2409_CR37","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.3390\/ijms232415489","volume":"23","author":"X Guo","year":"2022","unstructured":"Guo X, Yin X, Liu Z, et al. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci. 2022;23(24):15489.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2409_CR38","doi-asserted-by":"publisher","first-page":"828","DOI":"10.4093\/dmj.2020.0257","volume":"44","author":"JH Yoo","year":"2020","unstructured":"Yoo JH, Kim JH. Time in range from continuous glucose monitoring: a novel metric for glycemic control. Diabetes Metab J. 2020;44(6):828\u201339.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"2409_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/nu13010159","volume":"13","author":"GD Dimitriadis","year":"2021","unstructured":"Dimitriadis GD, Maratou E, Kountouri A, et al. Regulation of postabsorptive and postprandial glucose metabolism by insulin-dependent and insulin-independent mechanisms: an integrative approach. Nutrients. 2021;13(1):159.","journal-title":"Nutrients"},{"issue":"6","key":"2409_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2022.101377","volume":"48","author":"X Chang","year":"2022","unstructured":"Chang X, Bian H, Xia M, et al. Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease. Diabetes Metab. 2022;48(6): 101377.","journal-title":"Diabetes Metab"},{"issue":"1","key":"2409_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12876-022-02290-1","volume":"22","author":"A Sugiyama","year":"2022","unstructured":"Sugiyama A, Kurisu A, Bunthen E, et al. Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups. BMC Gastroenterol. 2022;22(1):241.","journal-title":"BMC Gastroenterol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02409-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02409-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02409-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T13:03:32Z","timestamp":1725109412000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02409-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2409"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02409-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"assertion":[{"value":"16 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol of the GNHS was approved by the Ethics Committee of the School of Public Health at Sun Yat-sen University, and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}